undamentalytics Newsletter
Sign in

Lensar, Inc. cash flow statement

In fiscal 2025, Lensar, Inc.'s operations generated −$14.8m of cash; it spent $83,000 on capital projects, leaving free cash flow of −$14.9m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−13−14−9−15−10−2−15−7
Depreciation and amortisation31222344
Stock-based pay09776333
Capital spending00000000
Free cash flow−13−14−9−15−10−2−15−7
Free cash flow after stock pay−13−23−16−22−15−5−18−10
Shares issued—16——————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CVRX vs LNSRAPT vs LNSRAPYX vs LNSR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Lensar, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lensar, Inc.